Transaction · 0001213900-26-109160

Keller Eric L.

Keller Eric L., CEO, reported an open-market or private purchase at Retension Pharmaceuticals, Inc. involving 20800.000000 shares for an estimated $249600.00. Reported holdings after the transaction were 423377.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO
RTSNRetension Pharmaceuticals, Inc.
Trade date
Oct 13, 2026
Filing date
Oct 13, 2026
View on SEC Insider profile
Estimated value$249kShares × reported price
Shares traded20.8k$12.00 per share
Holdings after423kDirect
% of reported position traded5.17%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 402,577 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RTSN price since this filing

Daily closing prices, with the filing date and available return windows
RTSN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago -2.7%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001213900-26-109160
Common Stock
Transaction date
Oct 13, 2026
Filed Oct 13, 2026, 10:12 PM · 0d delay
Shares
20,800 sh
$12.00 per share
Estimated value
$249k
Computed from shares × price
Holdings after
423,377 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CEO Buy Cluster Buy Director Buy Direct Ownership
Filing-only score

+48 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • ceo_buy+12 points

    is_officer + officer_title/role mentions CEO

    CEO open-market purchase.
  • cluster_buy+14 points

    cluster-buy signal matched

    Multiple insiders bought within the configured window.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF EXECUTIVE OFFICER

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial publ…

  2. F2

    Each share of Series B Convertible Preferred Stock (the "Series B Preferred Stock") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial publ…

  3. F3

    Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on August 14, 2027, with the remaining stock options vesting in 36 monthly incre…

Original filing · 0001213900-26-109160
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RTSN